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Abstract
In order to modify bacterial genetic codes, modifications must be made throughout the genome
wherever the affected codon is used. Making such numerous and widespread genomic changes
requires specialized techniques. MAGE is well-suited to this task, being highly amenable to
multiplexing and having low time and resource costs per site. MAGE has been used as a first
stage in recoding efforts, converting small clusters of sites in separate strains to be combined by
other means, but improvements in MAGE technique suggest the possibility of using it to produce
fully-recoded strains directly. To this end, I compare strategies based on co-selected MAGE and
apply the best by performing 80 site conversions spread over 1/4 of the E coli genome.
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Background
The near universality, with some notable exceptions [1], of the genetic code which specifies the
translation of nucleic acid sequences to polypeptides in natural lifeforms is a key fact of modem
biology. The genetic code's portability across species is the foundation for the use of
recombinant DNA, one of the primary components of modem biotechnology. The universal
compatibility of genetic code is also exploited in nature, with horizontal transfer of genes
between species.
Useful as the standardized genetic code is, there are many potential benefits to an
experimental organism with a different code. Some of the advantages spring from the simple
consequence of genetic incompatibility. An organism which follows an incompatible code could
be immune to natural viruses, due to mistranslation of virus genes. Bacteriophage contamination
of cultures is an industrially significant problem [2]. The same mutual unintelligibility could
prevent spontaneous horizontal gene transfer into or out of the organism. Preventing gene
transfer out of the experimental organism addresses some safety concerns for genetic engineering
by ensuring that novel engineered genetics are not able to spread into wild microbial populations
[3]. The incompatible organism would also be unable to make use of genes cloned directly from
organisms using the original genetic code, but the widespread availability of gene synthesis
makes recoded synthetic genes a viable substitute.
In addition to the inherent advantages of a sufficiently modified genetic code, certain specific
changes have interesting possibilities. There is significant interest in incorporating amino acids
outside the normal 20 into proteins. But the natural genetic code completely fills the coding
space. Since every possible sequence can be interpreted under the existing code, it is impossible
to unambiguously code for a novel amino acid. Current methods of incorporating non-natural
amino acids by translation are functional, but less than ideal. An engineered code can leave
some codons coding for nothing, as openings which could be used to encode non-natural amino
acids with greater efficiency [4] As well, the natural genetic code incorporates a mutation
tolerance mechanism by arranging for codons to be clustered in mutation space with codons for
the same or functionally similar amino acids. In nature, this improves mutation survival, but in
an engineered organism survivability is secondary to genetic stability. A sparse genetic code
where most mutations either result in meaningless codons which cause translation faults or code
for radically different chemistry might result in fewer viable mutants, and higher effective
genomic stability.
The Molecular Machines group led by Joseph Jacobson, part of the Center for Bits and Atoms
at the MIT Media Lab, in collaboration with George Church's group at Harvard Medical Center,
is working to produce useful working strains with recoded genomes supporting altered genetic
codes [5]. The planned rE. coli series [6] of E. coli strains includes both compression of the
genetic code to produce open codons and exchanging the meanings of codon groups to increase
genetic incompatibility.
Problem
The chief difficulty of re-engineering the genetic code of an organism is that each codon is
used at many locations distributed across the entire genome. In order to cleanly re-assign a
codon to a new role, the genome must be rewritten so that existing uses of the codon to be re-
assigned are replaced by another appropriate codon. Even the least frequently used codon in the
E. coli genome, the stop codon TAG, appears 314 times scattered across the 4.6 megabase
genome. This represents too many genomic changes to be feasible by conventional methods.
Two approaches to making the changes appear possible. Complete resynthesis of the genome
with desired changes, in an extension of recent work by the Venter group [7], or the multiplexed
MAGE [8] the Molecular Machines group has chosen for the rE. coli project, of which the
elimination of the TAG codon is the first stage.
Full genome re-synthesis promises the ability to implement any combination of desired
genomic changes in a single step, and at a flat price. However, synthesis of a full genome is an
expensive project, compared to a limited genome rewrite by other means. There is also the
problem of genome boot up, or getting the synthetic genome active in a live cell, which may be
difficult or impossible if the new genome has major incompatibilities with the host strain. If not
otherwise resolved, this might require building multiple intermediate genomes in order to
perform radical genetic code alterations, which would seriously undermine the advantages of the
approach. Among genome editing methods, MAGE, derived from earlier oligo-based Lambda
Red recombineering methods [9] stands out for codon reassignment. Using inexpensive oligos
rather than larger constructs, which limits costs, MAGE works best at replacing small patches of
genome, such as single codons or individual bases. MAGE has an extremely high baseline site
replacement rate and can accomplish much more by multiplexing, and still more when taking
advantage of co-selection [10], especially using doubly-selectable sites.
The rE. coli project spread the initial codon replacement across many strains in parallel, each
receiving 10 consecutive target codon changes. These are to be combined into a single fully
recoded strain by CAGE [5], a hierarchal conjugation-based strategy. At the time, converting the
majority of a 10 site group required required days of continual MAGE cycling. As well as being
time consuming, such extended cycling is mutagenic and there was concern that it would result
in the cells developing resistance to MAGE, as had been observed in previous experiments.
Developments in MAGE since, particularly including a better understanding of linkage and
performance enhancement by co-selection mean that today a single MAGE cycle followed by
selection and screening can produce a number of site conversions comparable to the 18-cycle
runs of unselected MAGE previously [5] used. This capability calls for a re-evaluation of how
large numbers of site conversions are best performed. Increasing the rate of site conversion by
MAGE directly increases the scale of feasible MAGE-based recoding projects, which is
necessary if more ambitious recoding projects such as the planned rE. coli 2.0 and 3.0 [6] are to
be carried out using MAGE genome editing.
Related Work
There is no work in large-scale purely MAGE-based genome editing approaching the scale of
this project. Our past work has included extensive experience with converting 10-site blocks,
and some investigation of larger groups of up to 20 sites. This project investigates the potential
of higher levels of multiplexing, and converts more total sites by MAGE alone than ever before
in a single strain.
CAGE offers a hierarchic collection scheme that thus far has been used to accumulate small
groups of changes initially made using basic MAGE. It has proven effective in producing
genomes with the same set of modifications as this project targets, and others of equivalent
complexity.
In the larger field of genome editing techniques, there have been a number of efforts which
have made similar or greater numbers of discrete changes, over equal or larger genomic spans.
Such major genome engineering exercises are reviewed in Carr and Church [3]. The MGF-01
minimized-genome K coli strain [11], with 53 sections of its genome removed, is a particularly
interesting case. Cassette-based recombineering for individual deletions and transduction-based
consolidation were used to produce a thriving strain with an appreciably reduced genome and
favorable growth compared to the ancestral strain.
Still farther afield, the Venter group's fully synthetic M mycoides genome [7] is the
forerunner of a powerful alternative to genome editing. While in fact only a handful of moderate
divergences from the natural sequence were made, for the sake of demonstration, the full re-
synthesis approach in principle should be capable of arbitrarily extensive and detailed genome
modification provided the altered genome is viable.
Methods
The 80 sites to be converted comprise 8 consecutive 10-site blocks out of the 32 that make up
the full list of TAG codons to be altered for rE coli 1.0 [5], specifically blocks 17 through 24,
spanning over 1.1 megabases. Each site is one of the 314 TAG stop codons of the E. coli
MG1655 genome, which are to be converted to TAA stop codons. Each block was to be
converted by two rounds of multiplexed co-selection enhanced MAGE. After each round,
colonies would be screened using two stages of qPCR to find a highly converted strain to
proceed with. The second MAGE round would then target only those sites not successfully
converted by the first round. Any sites still not converted after the second round would then be
rolled over to be converted in the next pair of MAGE rounds along with the next 10-site block.
In principle, it should be possible to perform two rounds of co-selected MAGE in 5 days.
One day to perform a MAGE round with tolC stop and begin selection, one day to plate for
colonies, one day to screen tolC- colonies, one day to perform a MAGE round with tolC restore
and plate for colonies, and one day to screen tolC+ colonies.
As exploratory options MAGE was attempted with 20 and 40 target oligos, spanning blocks
19-20 and 17-20, respectively. The MASC-qPCR assay is not effective on such large numbers of
sites. Addressing 20 or more targets in a single reaction works poorly due to cross-talk, and
splitting them among multiple 10-site reactions produces separate rankings which are of limited
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Figure 1: Illustration of rE coli 1.0 targets. Inward lines indicate dsDNA
recombineering frequency at selected sites. Outward lines indicate
conversion frequency of target sites after 18 rounds of standard MA GE.
From Isaacs et. al. [5]
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Figure 2: Illustration ofproposed model for MAGE co-selection, from Carr et. al. [10]
Integration of oligos at the replication fork results in multiple changes made in one round to
co-segregate, allowing selection for one target to enrich the population for conversion at all
targets.
use in picking out strains with many total conversions. So the resultant strains were screened on
only 10 targets. If the detrimental effect of the extra multiplexing on conversion of those 10
assayed sites was sufficiently low, extra conversions obtained in the un-screened targets might
accrue fast enough to improve the overall rate of conversion at the cost of additional assays to
assess intermediate strains at the additional sites.
Multiplex co-selected MAGE:
The basic MAGE method [8] can be made to yield much higher site replacement frequencies
by use of co-selection [10]. The basis of this method is that there is linkage between MAGE
replacement events which are sufficiently closely spaced. By making one of the replacements
selectable, one may obtain significantly enhanced performance at the multiplexed sites.
Linked selection can be provided on each cycle by using a doubly-selectable marker. For the
80-site replacement, the chosen method is creating and reverting a nonsense mutation in the tolC
gene, which codes for a transmembrane channel. Cells can be selected for both tolC+ and tolC-
genotypes [12] by using SDS and Colicin El, respectively.
The endogenous tolC gene is located at base pair 3176137, over 300kb toward the origin of
replication from the nearest of the 80 target sites. To position the selective marker more
conveniently, the ancestral strain has had endogenous tolC seamlessly deleted and re-inserted at
2223738, in between blocks 20 and 21. This position was anticipated to provide strong co-
selection for all sites in blocks 17-20, down-replicon from the marker, and an uncertain level of
co-selection to blocks 21-24. Fall-off of co-selection in the more distant up-replicon blocks was
a potential problem, as co-selection has observed to lose effect over similar up-replicon
distances.
qPCR strain screening:
The qPCR-based screen for highly converted strains uses two stages to examine a large
number of clones while keeping to a manageable number of reactions. The first stage
multiplexes over all target sites to allow tested clones to be roughly ordered by number of
conversions. The second stage tests a handful of the most favorable clones for conversion at
each target site.
The first stage uses multiplex allele-specific quantitative colony PCR (MASC-qPCR) [5]
across the current target sites. 191 colonies are tested, and the 15 highest rated are passed on to
the next stage.
The second stage uses the allele-specific colony qPCR to test each of the 15 top candidate
strains at each of the current targets individually, providing a selection of full genotypes from
which a strain can be chosen to begin the next cycle. The primary factor in the choice is total
number of sites converted, but choosing between strains with equally numerous but different sets
of conversions is necessary.
Materials:
Strain
The ancestral strain is EcNR1 [5], which is MG1655 with X-prophage::bioA/bioB. MutS was
deactivated by introducing a nonsense mutation by oligo recombineering. This strain was further
seamlessly deleted for endogenous tolC by oligo recombineering to prepare for reintroduction of
tolC by cassette recombineering. The resultant strain, EcNR1 mutS- AtolC (-> 20.21) responds
well to MAGE and has the tolC gene located within hopeful co-selection range of all desired
target sites. This strain is the ancestor of all other strains used in the experiment.
Oligos
The MAGE 90-mers and MASC-qPCR primers used are exactly those used in Isaacs et al. [5]
to convert and assess sites in regions 17 through 24. TolC function is toggled using the 90-mers
tolC on: tgggttcagttcgttgagccaggccgagaacctgatgcaagtttaTcagcaagcacgccttagtaacccggaat-
tgcgtaagtctgccgc and tolC off: tgggttcagttcgttgagccaggccgagaacctgatgcaagtttaAcagcaagcacgcct-
tagtaacccggaattgcgtaagtctgccgc.
Techniques:
Co-selected MAGE
In each round of MAGE, a clonal liquid culture was used to inoculate 20 mL low salt (5g/L)
Luria Broth (LSLB) in a baffle flask. This culture was grown at 30'C with agitation at 250 RPM
to mid-logarithmic growth, determined by OD600 of 0.3-0.6. To induce the X Red genes the
flask was transferred to a shaking water bath at 420C for 15 minutes, after which it was
immediately placed on ice and moved to a 4* environment to be prepared for electroporation.
After the culture has chilled, two 1 mL samples were withdrawn. Each was pelleted by
centrifugation at 16100 g for 1 minute, and the supernatant fully removed, with repeat
centrifugation as necessary. The pellet was then resuspended in 1 mL pure water. The pelleting
and resuspension was then repeated, followed by a further pelleting and removal of supernatant.
The pellets were then resuspended together in 90 jL pure water.
In duplicate, 45 jL of the electrocompetent cells was then added to 5 jL of MAGE 90-mer
mix, for a final concentration of 990 nM total target site TAA -> TAG 90-mers, evenly divided
among sites, and 10 nM tolC stop or toiC restore 90-mer for co-selection. This was transferred
cold to a chilled electroporation cuvette with 1mm gap, and electroporated using a Bio-Rad Gene
Pulser Xcell at 1800 V, 25 pF, 2002. The electroporated cells were immediately resuspended in
1 mL LSLB.
When the co-selection oligo used was tolC restore, the full 1 mL was taken from the cuvette
and added to another 1 mL LSLB in a culture tube. This was then allowed to recover at 30*C
with agitation for 1 hour before plating 80 pL on LSLB agar with carbenicilin and 0.005% SDS
to isolate tolC+ colonies.
When the co-selection oligo used was tolC stop, 50 jL was taken from the cuvette and
inoculated into 2 mL LSLB. This was allowed to recover and grow at 30*C with agitation for no
less than 5 hours. After diluting if necessary, it was then allowed to grow to mid-log and OD600
of 0.4 to 0.6. At the same time, a known tolC+ culture was brought to the same state of growth
to serve as a negative. Each of these was used to inoculate a tube of 2 mL LSLB and 20 jL
colicin El preparation with 20 jL cell growth. These cultures were allowed to grow for 8-12
hours, until the electroporation-derived cultures become confluent. Each was then plated at 10'
and 10' dilutions onto LSLB agar with carbenicilin.
qPCR site assay
MASC-qPCR is performed as described in Isaacs et al. [5], with the exception that the
combined primer concentration of 1 pM is divided evenly among whatever set of primers is
required by the current reaction, covering up to 12 sites. Attempting larger numbers of sites
results in increased crosstalk between the primer pairs, reducing the usefulness of the result.
Prospective colonies are ranked in descending order of A-Ct. A single wild-type control is
included for comparison.
Allele specific colony qPCR uses the same procedure as MASC-qPCR, but includes only a
single primer pair in each reaction. A wild-type control colony is required to ensure that the
unconverted genotype is represented among the samples. The AACt indicative of positive
conversion is highly site-dependent, but a set of colonies including both TAG and TAA
genotypes offers distinctively bimodal ACt values which can be evaluated by examination. In
some cases intermediary ACts may be observed. Samples exhibiting such results should be
avoided, as it may indicate a non-clonal cell sample or an undesired mutation close to the target
site.
Implementation and Results
Results of co-selected MAGE rounds to produce the 80-site converted strain are detailed in
table 1. A number of rounds featured modifications to the standard plan or showed unexpected
effects.
Round 1: Only 64 colonies in MASC-qPCR screen, and only 7 passed to the second-stage assay.
Round 3: Test-plated leading strains for SDS sensitivity. All tested positive.
Post-Round 6: Allele-specific qPCR tested current strain at all sites in blocks 18-20. All sites
were found to be converted to TAA except 20-8, contrary to the result after round 2.
Round 7: Test-plated winner to confirm SDS sensitivity.
Round 8: Based on later results, 20-7 was restored to wild type in the process of converting 20-8
in this round. The 20-7 and 20-8 90-mers each overlap the other's target site and frequently
overwrite it to wild-type.
Round 10: Expanded second-stage screen to 31 colonies.
Round 12: Plating at 1 hour growth yielded insufficient colonies. Replating after further
outgrowth was required.
Round 13: Test-plated leading strains for SDS sensitivity. 14 of 15 tested positive.
Round 14: Cells recovered 90 minutes before plating, yielded insufficient colonies. Only 95
colonies screened.
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Figure 3: Plot of conversion progress
Round 15: Both electroporations arced. After colicin selection, estimated 1/4th of colonies are
tolC-. Of 15 chosen for second-stage screen, 7 proved to be SDS sensitive on test-plating. One
of these was chosen for continuation.
Round 16: Allowed recovery for 5 hours 40 minutes, plated at 1 and 10 fold dilution.
Round 17: Plating produced limited colonies, so only 143 colonies were available for MASC-
qPCR screen.
Post-Round 17: In preparation for the final round, the current strain was assessed at all 80 sites
by allele-specific qPCR. All sites were found to be converted except for 23-9, 24-9, and 20-7.
Round 18: Recovery extended to overgrowth, then plated at 103, 104, and 10' fold dilution. Site
screen included 20-8 as well as the target sites in an effort to recover a colony in which the 20-7
90-mer did not overwrite 20-8. The second stage of qPCR screening was expanded to examine
46 colonies, of which 8 were contaminated by pipetting error.
From electroporation for round 1 to second stage screen for round 18, the process ran 85 days.
That is nearly double the 45 days that in theory should suffice to run this number of rounds.
Round Selective 90mer Targets Converted
1 tolC stop All block 20 sites 20-1, 20-3, 20-5, 20-6, 20-10
2 tolC restore 20-2, 20-4, 20-7, 20-8, 20-9 20-2, 20-4, 20-7, 20-8*
3 tolC stop 20-9, all block 19 sites 20-9, 19-3, 19-4, 19-5, 19-7, 19-9, 19-10
4 tolC restore 19-1, 19-2, 19-6, 19-8 19-1, 19-2, 19-6, 19-8
5 tolC stop All block 18 sites 18-1, 18-2, 18-6, 18-7, 18-8, 18-10
6 tolC restore 18-3, 18-4, 18-5, 18-9 18-3, 18-4, 18-5, 18-9
7 tolC stop All block 17 sites 17-1, 17-2, 17-4, 17-5, 17-8, 17-9, 17-10
8 tolC restore 17-3, 17-6, 17-7, 20-8 17-3, 17-6, 20-8
9 tolC stop 17-7, all block 21 sites 21-1, 21-2, 21-3, 21-4, 21-5, 21-8, 21-9, 21-10
10 tolC restore 21-6, 21-7, 17-7 21-6, 21-7, 17-7
11 tolC stop All block 22 sites 22-1, 22-2, 22-5, 22-6, 22-7, 22-8, 22-9
12 toIC restore 22-3, 22-4, 22-10 22-4, 22-10
13 tolC stop 22-3 and all block 23 sites 22-3, 23-3, 23-6, 23-7, 23-10
14 tolC restore 23-1, 23-2, 23-4, 23-5, 23-8, 23-9 23-2, 23-4, 23-8
15 tolC stop 23-1, 23-5, and all block 24 sites 24-1
16 toIC restore 23-1, 23-5, 23-9, and 24-2 to 24-10 23-5, 24-2, 24-4, 24-5, 24-6, 24-7, 24-8
17 tolC stop 23-1, 23-9, 24-3, 24-9, 24-10 23-1, 24-3, 24-10
18 tolC restore 20-7, 23-9, 24-9 23-9, 24-9
Table 1: Production MAGE rounds. *20-8 was detected as converted in round 2 but as
unconverted after round 6. It is accounted as having been converted in round 8.
Highly Multiplexed Co-selected MAGE Test
The trial of higher multiplexed MAGE used 64 clones in the first stage and 4 in the second
stage screen for each of the two tested scales. In both cases, few conversions were detected in
block 20. With the 20-target 19-20 MAGE pool, only 20-2 and 20-5 were found converted.
With the 40-target 17-20 pool, 20-3, 20-4, and 20-10 were obtained. On assaying the top strains
at the unscreened sites, the 19-20 winner was found to be converted at 19-9, for a total of 3
conversions, while the 17-20 winner was found to be converted at 17-1 and 17-10, bringing its
total to 5. Considering that the latter result was obtained with only 4 second stage clones rather
than 7, it could be considered stronger than the 5 obtained from the conventional 10-site pool of
block 20 only. However, the prospect of an expected 4 rounds to fully convert block 20, with
little likelihood that blocks 19, 18, and 17 would all follow in a single round each, was
considered unfavorable compared to 10-site pools which were strongly expected to convert a
block every 2 rounds.
Discussion
Potential Improvements
Although the tested possibilities for improving performance were rejected, an opportunity for
increased performance is evident from examining the results of the cycles. Cycles targeting 10
or more sites (rounds 1, 3, 5, 7, 9, 11, 13, 15, and 16) produced a median of 7 changes. The other
cycles targeted at most 6 sites, and converted no more than 4. (See figure 4 or table 2). What
this indicates is that to get many conversions, it is advisable to target many sites on every cycle.
This could easily be implemented by adding new targets to the current set every cycle such that
each cycle covers 10 to 12 sites, rather than introducing new targets 10 at a time on a rigid
schedule. Simply adding one new target for each target converted should suffice.
Doing so might yield a conversion rate of roughly 7 sites per cycle until fewer than 10
unconverted targets remain. However, the process might be stalled by an accumulation of
refractory sites as present targets. Some conversions are known to be significantly less likely to
appear than others [5], and it is likely the case that some conversions make a weaker contribution
to the MASC-qPCR signal and are thus less likely to be isolated after screening. Such
conversions, when in a target pool with less-refractory targets, may be at risk of persistently
failing to appear in the strain chosen for propagation. Rounds in which there are fewer targets
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Figure 4: Comparison of number of targets and number of conversions made across the 18
rounds of co-selected MA GE. *Due to arcing, round 15 is not comparable to other
rounds, but is included for completeness.
increase the 90-mer fraction dedicated to each and decrease competing signals in the MASC-
qPCR, both of which would improve the chances of obtaining the problematic conversion.
This more fluid approach might better harness the potential of using larger multiplexed pools
as well. With a rolling set of assayed sites rather than a fixed block by block frame, fully
converting blocks ceases to be a hurdle. The sole factor becomes how many site conversions can
be obtained per cycle, which this study has not firmly established. The necessary addition of an
assay step to determine which conversions outside the screened set would be a minor cost.
Based on the limited test, 40-site multiplexing with screening at 10 sites might yield more total
conversions than the standard 10 site fully screened pool, but further testing is needed. In light
of the success of up-replicon co-selection as far as block 24, 80-site pools should be considered
as well as the smaller pools tested for this project.
Based on the extremely poor performance of cycle 15, it would be advisable to discard any
MAGE electroporation that arcs and prepare fresh cells. Even if an extra day of work is
required, less time would be lost than in completing such an unproductive cycle.
Avoiding MAGE oligos which overlap and revert neighboring sites, such as those targeting
sites 20-7 and 20-8, is also strongly advised. It is possible to convert both sites by MAGE in
such a case[5], but the difficulty can be avoid either by modifying the oligos to stop short of the
next target, or by making oligos which cover multiple sites reflect the desired change at all of
them.
Performance and potential
Co-selected MAGE has proven to be a viable method for genome-editing on the 80-site scale.
Over the course of 18 cycles of MAGE, 79 of the 80 desired edits were obtained with no
discernible breakdown of the genome modification process. It is expected that a number of off-
target mutations will have accumulated in the genome due to long propagation in a mutS- state
and repeated k-red induction, but MAGE performance does not appear to have suffered the fall-
off sometimes seen after many cycles of non-selected MAGE [5], nor has tolC selectability
failed. Notably there does appear to be a possible decrease in rate of conversions in the later
rounds, starting at round 13. The downturn is slight enough to be attributed to chance, but might
also be indicative of weaker co-selection far up-replicon of tolC, or even a slight reduction in the
strain's MAGE performance. It might also indicate an increased frequency of recalcitrant targets.
Although there is no accumulation of problem sites from earlier blocks, block 23 may be
intrinsically challenging. In light of the high performance of round 16 any general drop in
MAGE performance cannot be severe, but followup assessment the final strain's performance is
called for.
This stability is likely a result of the complex selection pressure which is regularly applied
throughout the process. To be propagated from one round to the next a strain need not only pass
selection on tolC, but must be picked out as highly converted by the two-stage screen, and can at
the same time be tested against the possibility of having subverted the primary selection by
attaining a phenotype resistant to both SDS and colicin El. In light of this success over 80
targets, this suggests that this method of MAGE with co-selection is stable and robust, and
capable of scaling to larger tasks.
As a method capable of large-scale site editing, the co-selected MAGE method's nearest
comparison is to the MAGE-CAGE hierarchical method. Recently, a strain converted at the
same 80 sites was obtained by MAGE-CAGE [5]. Reportedly [Lajoie, MJ, private
correspondence] strain construction with CAGE took approximately 5 weeks. Even accounting
for time to generate the 10-site converted strains that are precursors to CAGE assembly, that is
substantially less time than was required by the MAGE-only method, and somewhat faster than
the theoretical potential speed of 18 rounds of the co-selected MASC-qPCR screened MAGE
method. Nonetheless, co-selected MAGE offers some potential advantages.
The co-selected MAGE process scales linearly, converting new sites at a steady pace by
simple repetition. While this leads to much slower progress on larger tasks than logarithmic
scaling methods like hierarchical CAGE, it also means that the process is scale-invariant.
Extending the current work from an 80-site quarter genome to a 160 site half genome is simply a
matter of repositioning the toIC gene and perforning another series of cycles. While time
consuming, this process could potentially convert the full 314 targets for rE. coli 1.0 in less than
a year. Hierarchical CAGE might achieve the same far faster, but calls for larger conjugative
genomic transfers to do so, potentially facing novel challenges.
Scaling down instead of up, co-selected MAGE remains well-suited to making a smaller
number of changes. A single cycle of screened co-selected MAGE achieves slightly fewer
changes than 18 cycles of unselected MAGE [5], but takes less time and avoids risk of
phenotypic drift seen in the unselected process. Unselected MAGE can, ideally, be performed at
a rate of one cycle per 2-2.5 hours, and screening 47 clones after 18 cycles with 10 90-mers can
be expected to produce a strain with 8 conversions [5]. Based on this, and supposing that no
problems arise from iterating that process, a plausible model for open-ended MAGE processing
is 3 days of cycling at 6 cycles per day, followed by one day screening clones, to produce 8 site
conversions every 4 days. This is much quicker than the co-selected method as performed,
which yielded slightly less than one conversion per day on average. However the necessary
steps for a co-selected MAGE round can be performed in 2.5 days, on average. With a rolling
set of 11 targets, the expected yield would be 7 conversions per 2.5 days, 40% higher than the
non-selected projection. In addition to now-proven stability, use of co-selection does offer the
possibility of moderately more rapid MAGE genome editing.
The requirement for a selectable marker adds some overhead to co-selected MAGE, but is
likely worthwhile for 20+ edits. On a smaller scale still, the overhead required by co-selection
will likely overwhelm any time benefit for 4 or less sites. However, on 4 sites or less, screened
co-selected MAGE has been observed to obtain full conversion in a single electroporation,
avoiding any intermediate genotypes. This might be valuable for some manipulations, such as
introducing a mutation in one gene and a compensatory mutation in another together, or
reconfiguring genetic controls for a synthetic pathway.
Conclusion
Co-selected MAGE is capable of genome editing on the 80 site quarter genome scale, though
not as fast as MAGE-CAGE. While its linear method makes it likely to scale to larger tasks,
such as the 314 targets of rE. coli 1.0 [6], with minimal technical problems, linear scaling of
project time is very unfavorable compared to the logistic time scaling of hierarchical methods.
Because of this co-selected MAGE is unsuitable as the sole method for creating strains with very
large numbers of changes, such as the thousands or tens of thousands required for larger genome
recoding projects. However, for smaller scale projects of 40 or less changes, it has potential to
be faster than either MAGE-CAGE or non-selected MAGE cycling. This could include initial
production of changes to be accumulated by MAGE-CAGE.
Co-selection greatly increases the number of changes made per MAGE cycle and has
potential to substantially improve the rate of changes over time, provided that an appropriately
positioned doubly-selectable marker is available. Combined with fast, scar-less recombineering
to manipulate markers, this makes it an appealing method for making moderate numbers of
changes over a megabase-scale area of the genome.
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Supplemental Data
Round Total Round Conversions First stage Second stage
Conversions Targets screen screen
1 5 10 5 64 7
2 8 5 3 191 15
3 15 11 7 189 15
4 19 4 4 191 15
5 25 10 6 191 15
6 29 4 4 191 15
7 36 10 7 191 15
8 38 4 3 191 15
9 46 11 8 191 15
10 49 3 3 191 31
11 56 10 7 191 15
12 58 3 2 191 15
13 63 11 5 191 15
14 66 6 3 95 15
15 67 12 1 191 15
16 74 12 7 191 15
17 77 3 3 143 15
18 79 2 2 191 38
Table 2: Numerical summary of conversions and tabulation of number of clones screened.
Colonies discarded due to contamination are not included
Site Gene 18-cycle MAGE rate Rounds to convert
17-1 ydhM 60.0 1
17-2 lhr 73.3 1
17-3 ynhG --- 2
17-4 sufA 47.7 1
17-5 ydiA 37.8 1
17-6 ydiE 43.9 2
17-7 nlpC 13.3 4
17-8 btuC 22.0 1
17-9 arpBl 69.8 1
17-10 ydjX 64.9 1
18-1 nudG 64.3 1
18-2 b1788 35.6 1
18-3 yeaL 15.6 2
18-4 yeaX 17.8 2
18-5 yobB 31.1 2
18-6 exoX 14.7 1
18-7 yecN 56.5 1
18-8 otsA 28.9 1
18-9 dcyD 10.9 2
18-10 yedM 32.6 1
19-1 fliE 34.8 2
19-2 fliN 25.5 2
19-3 fliP 47.8 1
19-4 fliQ 34.1 1
19-5 yedSl 45.5 1
19-6 cbl 31.9 2
19-7 b1996 32.6 1
19-8 hisL 42.2 2
19-9 wbbJ 62.8 1
19-10 wcaM 47.4 1
20-1 wcaL 17.0 1
20-2 wcaC 45.7 2
20-3 asmA 20.0 1
20-4 baeR 21.7 2
20-5 gatR_1 36.2 1
20-6 tra5 4 17.8 1
20-7 yegV 28.3 2
20-8 yegW 17.4 3*
20-9 yehQ 38.3 3
20-10 yohC 70.2 1
21-1 yohF 33.3 1
21-2 sanA 85.2 1
21-3 yejA 25.0 1
21-4 yejE 33.3 1
21-5 b2191 21.1 1
21-6 rcsD 34.9 2
21-7 rcsC 26.8 2
21-8 yfaT 50.0 1
21-9 menF 70.0 1
21-10 yfcO 2.9 1
22-1 yfcU 21.7 1
22-2 tfaS 29.8 1
22-3 ypdI 23.4 3
22-4 yfdY 21.7 2
22-5 yfeO 48.9 1
22-6 mntH 14.9 1
22-7 xapR 8.7 1
22-8 yfeR 23.4 1
22-9 yffB 41.3 1
22-10 hda 23.4 2
23-1 yfgG 6.8 4
23-2 pbpC --- 2
23-3 yphA 17.0 1
23-4 yfhB 27.7 2
23-5 kgtP 38.3 3
23-6 yfiA 22.7 1
23-7 yfjQ 38.6 1
23-8 yfjR 17.0 2
23-9 ypjC 26.5 5
23-10 ygaQ 40.9 1
24-1 ygaR 57.1 1
24-2 yqaC 40.0 1
24-3 gabT 22.0 2
24-4 ygaU 37.2 1
24-5 ygaM 20.9 1
24-6 luxS 30.2 1
24-7 mItB 36.4 1
24-8 srlE 43.9 1
24-9 norW 14.6 3
24-10 ascB --- 2
Table 3: Conversion rate and rounds to conversion by site. 18-cycle MAGE rate is the frequency
of conversion after 18 unselected MAGE rounds, as reported in Isaacs et. al. [5]. Rounds to
convert is the number of rounds of co-selected MAGE the site was targeted in before being
converted. Round 15 is not counted, except for 24-1, due to arcing. *20-8 is problematic due to
its 90-mer overlapping 20-7, and due to its false positive in round 2.
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Figure 5: Scatter plot of rounds to conversion versus reportedfrequency in 18
unselected MAGE cycles, as listed in Table 3. Ofpossible note, all sites with
frequencies over 50% were converted on the first round that they were present.
